Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Researcher

Medical Science · Vietnam · 2025-01-11

Processing Time
297 days
Decision Date
2025-01-11
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in medical science by investigating molecular pathways involved in tumor proliferation. Her work focuses on developing targeted inhibitors and antibodies designed to slow or prevent cancer progression and improve patient monitoring in clinical settings.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research into molecular pathways of tumor proliferation aligns with national priorities for precision medicine and healthcare innovation.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record in the top 10% of the field, and history of competitive grant funding demonstrate her capacity to lead this work.

3 Balance of Interests Met

On balance, the petitioner's contributions to cancer treatment and medical innovation make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Medical Science and her record of six peer-reviewed journal articles and one abstract with 42 citations. Her influence was demonstrated by two papers ranking in the top 10% of most-cited publications in clinical medicine and significant funding from agencies like the Japan Agency for Medical Research and Development (AMED).

Request for Evidence (RFE)

Successfully Addressed

The RFE challenged the petitioner's qualifications and the national importance of the work; the response used evidence-based arguments to clarify the global impact of her cancer research.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorBalance of Interests

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Reference Letters Dependent
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Vietnam

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 297 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Vietnam All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist